David Mutimer

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

Graham R. Foster, William L. Irving, Michelle Cheung et al. · Journal of Hepatology · 2016 · 492 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Selection of Mutations in the Hepatitis B Virus Polymerase During Therapy of Transplant Recipients With Lamivudine

Roger Ling, David Mutimer, Mélika Ben Ahmed et al. · Hepatology · 1996 · 465 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +14

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Michael P. Manns, Didier Samuel, Edward Gane et al. · The Lancet Infectious Diseases · 2016 · 446 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +16

Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

Michelle Cheung, Alex J Walker, Ben Hudson et al. · Journal of Hepatology · 2016 · 408 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

Leonie Grellier, David Mutimer, Mèlika Ben Ahmed et al. · The Lancet · 1996 · 396 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16